Legal Affairs
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
Relm Launches Kidnap & Ransom Insurance for Cannabis Businesses
HAMILTON – Bermuda-based Relm Insurance announced a new Kidnap and Ransom (K&R) insurance product aimed at executives and operators in the Cannabis sector, alongside those in digital assets. The policy addresses physical threats that have ...
Glass House and Vireo Combine California Retail Ops to Form New JV
LONG BEACH – Glass House Brands Inc. and Vireo Growth Inc. announced that they will combine their California dispensary operations into a 50/50 joint venture aimed at creating one of the state’s largest Cannabis retail ...
Legal U.S. Cannabis Markets Generated Over $6B in Q1 2026
LOS ANGELES – Legal Cannabis markets across the United States generated $6.6 billion in sales during the first three months of 2026, according to compiled and released state regulatory data. The figure, which includes adult-use ...
Week in Review: Cannabis & Psychedelics Industry Highlights
The last fortnight delivered sustained progress across the U.S. Cannabis sector and meaningful steps forward in Psychedelics, showcasing the tangible outcomes that stem from a balance of ambition and discipline. State programs posted solid numbers, ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
Pallas Capital Advisors LLC Increases Investment in Tilray Inc.
LOS ANGELES- Pallas Capital Advisors LLC has significantly increased its investment in Tilray Inc, a company in the cannabis industry. According to the firm's latest 13F filing with the Securities and Exchange Commission, Pallas Capital ...
Ascend Wellness Secures $15 Million in Private Placement to Bolster Growth Initiatives
LOS ANGELES- Ascend Wellness Holdings, Inc. a multi-state, vertically integrated cannabis operator, has successfully completed a $15 million private placement of its 12.75% Senior Secured Notes due 2029. These notes were issued at 97% of ...
President Trump’s Role in Cannabis Rescheduling and Federal Reform
LOS ANGELES- President Donald Trump is poised to significantly influence the trajectory of federal cannabis policy, particularly concerning the rescheduling of marijuana under the Controlled Substances Act (CSA). The rescheduling process, initiated under the previous ...
Virginia Senate Committee Advances Bill to Legalize Recreational Cannabis Sales
LOS ANGELES- On January 17, 2025, the Virginia Senate Rehabilitation and Social Services Committee approved Senate Bill 970 (SB 970) with an 8–7 vote along party lines. Introduced by Senator Aaron Rouse (D-Virginia Beach), the ...
The Important Tax Deadlines to Remember in Cannabis
LOS ANGELES—As we enter 2025, it's crucial for individuals and businesses to keep track of key tax deadlines. Missing these dates can lead to penalties, interest charges, and wasted opportunities for tax savings. At Growise ...
Senator Warren Seeks Clarification from RFK Jr. on Cannabis Legalization and Rescheduling
LOS ANGELES- Senator Elizabeth Warren (D-MA) has formally requested that Robert F. Kennedy Jr., the nominee for Secretary of Health and Human Services (HHS), clarify his stance on cannabis legalization and rescheduling. In a comprehensive ...
Virginia Officials Advocate for Automatic Sealing of Cannabis Possession Records
LOS ANGELES- Virginia state officials are advocating for legislative measures to automatically seal all criminal records related to simple cannabis possession without the necessity of court orders. The Virginia State Crime Commission (VSCC) has endorsed ...
Analysis: Pennsylvania’s Cannabis Industry: Current Growth and Future Projections
NEW YORK- The cannabis industry in Pennsylvania continues to evolve, with medical cannabis already generating over $1.5 billion in annual sales. Discussions about recreational legalization are intensifying, particularly as the state's budget deficit grows and ...
Arkansas Governor Proposes Funding Free School Meals with Medical Cannabis Tax Revenue
LOS ANGELES- Arkansas Governor Sarah Huckabee Sanders has announced plans to allocate tax revenue from medical cannabis sales to fund free school meals across the state. In her State of the State address, Governor Sanders ...
Vireo Growth Completes $81 Million Equity Offering
LOS ANGELES- Vireo Growth Inc., a Minneapolis-based cannabis multistate operator, has successfully concluded an oversubscribed private placement, raising approximately $81 million. Initially targeting $75 million, the company issued 129,536,874 subordinate voting shares at $0.625 per ...
Biden Commutes Sentences of Nearly 2,500 Nonviolent Drug Offenders
LOS ANGELES- President Joe Biden has commuted the sentences of approximately 2,500 individuals convicted of nonviolent drug offenses, marking a significant use of executive clemency. This action aims to address past disparities in drug-related sentencing, ...
New York Supreme Court Halts Warrantless Raids on Licensed Hemp Retailers
LOS ANGELES- In a recent decision, New York State Supreme Court Justice Thomas Marcelle issued an injunction against the New York State Cannabis Control Board (CCB), the Office of Cannabis Management (OCM), and the New ...
Indiana Legislators Introduce Cannabis Legalization and Psilocybin Research Bills
LOS ANGELES- Indiana lawmakers have initiated efforts to reform the state's drug policies in the 2025 legislative session, introducing several bills aimed at legalizing cannabis and funding psilocybin research. Cannabis Legalization Proposals Senate Bill 113, ...
Colorado Considers Psilocybin Prescription Legislation
LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug ...
Chairman of High Times Parent Company to Plead Guilty in Fraud Scheme
LOS ANGELES-Adam Levin, chairman of Hightimes Holding Corp., has agreed to plead guilty to conspiracy charges involving a scheme to pay an investment analyst to promote the company’s stock without disclosing the compensation. According to ...
High Tide Acquires Majority Stake in German Cannabis Firm
LOS ANGELES- High Tide Inc., a Canadian cannabis enterprise, has acquired a 51% stake in Frankfurt-based pharmaceutical company Purecan for approximately €4.8 million. This strategic move marks High Tide's entry into Germany's medical cannabis market. ...
DEA Judge Cancels Cannabis Rescheduling Hearings
LOS ANGELES- The Drug Enforcement Administration (DEA) has canceled its upcoming hearings on the proposed rescheduling of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney issued the cancellation following legal challenges ...
Hemp vs Cannabis Beverages: What’s the Difference, and Why Does It Matter?
LOS ANGELES- Cannabis and hemp beverages markets see rapid growth, but their distinctions remain unclear to many. While both originate from one species, they cater to vastly different audiences, serve distinct purposes, and adhere to ...
The Rise of a New Era of Consumption: Cannabis-Infused Drinks
LOS ANGELES--Cannabis-infused beverages have rapidly gained traction in recent years as a popular alternative to traditional consumption methods such as smoking and vaping. With the increasing legalization of cannabis in the United States and other ...
What You Need to Know Inventory Management and Cost Accounting
LOS ANGELES—Every entrepreneur, CEO and CFO needs to know that effective inventory management and accurate cost accounting are critical to success in the cannabis and psychedelic industries. As businesses navigate a landscape marked by strict ...
Worried About IRS Audits? What You Need to Know
LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market ...
Psilocybin Therapy Shows Promise for Pandemic-Induced Depression in Healthcare Workers
LOS ANGELES- Recent studies indicate that psilocybin-assisted psychotherapy may alleviate depression among healthcare professionals affected by the COVID-19 pandemic. A randomized clinical trial conducted by the University of Washington involved 30 frontline clinicians experiencing moderate to ...
Efficacy of Medical Cannabis in Treating PTSD Remains Uncertain
LOS ANGELES- The use of medical cannabis as a treatment for post-traumatic stress disorder (PTSD) has garnered significant attention. However, current research provides limited and inconclusive evidence regarding its effectiveness. A 2021 systematic review found ...
Compass Pathways Advances Psilocybin Research in the UK
LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...
Hemp-Derived CBD Market Set to Expand Significantly by 2034
LOS ANGELES- The global hemp-derived cannabidiol (CBD) market is forecasted to grow from $8.28 billion in 2023 to $46.25 billion by 2034, with a compound annual growth rate (CAGR) of 16.93%, according to Research and ...
